Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00418522 · ClinicalTrials.gov registry record · Phase 4
This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes Mellitus
A Phase 4 study, sponsored by Pfizer.
- Completed
- Registry status
- Phase 4
- Development phase
- 413
- Enrollment target
NCT00418522: Completed Phase 4 study, sponsored by Pfizer.
NCT00418522 is a Phase 4 study that has completed, run by Pfizer. The registered enrollment target is 413 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (20% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00418522, a Phase 4 study, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 413 participants
- Enrollment target
Study Summary
This study is to determine if inhaled insulin is effective in treating type 2 diabetes mellitus.
Primary Outcome
HbA1c lab value: Change = value at Week 26 minus value at Baseline.
Interventions
- DRUG Insulin glargine
- DRUG Inhaled Insulin (Exubera)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 413 participants |
| Start Date | 2007-03 |
| Est. Completion | 2008-08 |
| Phase | Phase 4 |
What the finished NCT00418522 record still lists
NCT00418522 is an interventional study that assigns participants to a tested intervention. The registered 413 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (20% lower).
The record links to 0 conditions, and to 2 interventions - of which Insulin glargine is the first listed.
NCT00418522 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00418522 about?
NCT00418522 is a clinical study titled "This Study Is To Determine If Inhaled Insulin Is Effective In Treating Type 2 Diabetes Mellitus". This study is to determine if inhaled insulin is effective in treating type 2 diabetes mellitus.
What is the current status of trial NCT00418522?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 413 participants. The study started on 2007-03. Estimated completion is 2008-08.
What interventions are being tested in trial NCT00418522?
The interventions under investigation include: Insulin glargine (DRUG), Inhaled Insulin (Exubera) (DRUG).
Who is sponsoring clinical trial NCT00418522?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00418522's enrollment target sits among peer trials
413 205th of 2000 higher than 1,796 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03592472 · 413 participants · Phase 3
A Study of Pazopanib With or Without Abexinostat in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma (RENAVIV)
- NCT06697197 · 413 participants · Phase 1
A Study of BMS-986482 Alone or as Combination Therapy in Participants With Advanced Solid Tumors
- NCT04776941 · 414 participants · NA
Expressive Writing for the Management of Stress in Cancer Survivors
- NCT06792552 · 414 participants · Phase 1
A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia